The chronic lower back pain market was valued at US$ 2.46 billion in 2023 and is predicted to reach US$ 6.12 billion by the end of 2033, representing an impressive CAGR of 9.52% from 2024 to 2033. The increasing geriatric population with arthritis is one of the leading causes of chronic lower back pain, which is driving the market’s growth.
Download a sample of this report @ https://www.towardshealthcare.com/download-statistics/5156
Key Takeaways/ Important Points to Note
- North America has held a largest revenue share of 48.12% in 2023.
- By drug class, the non-steroidal anti-inflammatory drugs segment has contributed more than 26% of revenue share in 2023.
- By drug class, the opioids segment held the second-largest share of the market and is expected to grow at the fastest rate during the forecast period.
- By route of administration, the oral segment dominated the chronic lower back pain market in 2023.
- By route of administration, the topical segment is growing significantly in the market.
- By distribution channel, the retail & online segment dominated the chronic lower back pain market in 2023.
Industry at a Glance
The chronic lower back pain market deals with all the aspects associated with chronic lower back pain, which includes research & development, development of medication, disease monitoring, treatment, and post-treatment care. Even after an original injury or underlying cause of acute low back pain has been addressed, lower back pain that persists for more than 12 weeks or three months is referred to as chronic low back pain (CLBP). In the past ten years, the frequency of CLBP in adults has climbed by over 100%, and as the population ages, it will continue to rise sharply, impacting men and women of all ethnic backgrounds. Some of the main reasons for lower back pain are age, smoking, heredity, degree of fitness, weight increase, and occupational variables, in addition to mental health issues. Healthcare facilities, drug manufacturers, pharmacies, academic institutions, research centers, and assisted living facilities all play a role in the expansion of the chronic lower back pain market.
Top Companies of the Chronic Lower Back Pain Market
- SpineThera Inc. (U.S.)
- Pfizer Inc (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Johnson & Johnson Private Limited (U.S.)
- Medtronic (Ireland)
- Endo Pharmaceuticals Inc. (Ireland)
- Sanofi (France)
- Merck & Co Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Vertebral Technologies, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Dr. Reddy’s Laboratories Ltd. (India)
- Astellas Pharma Inc. (Japan)
- CELGENE CORPORATION (U.S.)
Segments Covered in Chronic Lower Back Pain Market Report
By Drug Class
- Non-steroidal Anti-inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
By Route of Administration
- Oral
- Topical
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/chronic-lower-back-pain-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5156
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare